SOMERSET, N.J., June 7, 2010 (GLOBE NEWSWIRE) -- inVentiv Health, Inc. (Nasdaq:VTIV), a leading provider of commercialization solutions to the global healthcare industries, was recently featured in a series of blog postings and an online interview about best business practices published by Fast Company blogger Kaihan Krippendorff.

Mr. Krippendorff is a former McKinsey consultant, author of three business strategy books and a blogger for Fast Company, a leading business magazine with a focus on technology, innovation, sustainability and design. Mr. Krippendorff's blog features the innovative practices of companies that have achieved uncommon success in their industries, such as Vistaprint, Rosetta Stone and Urban Outfitters.

In his blog series and in an online interview with Blane Walter, Chief Executive Officer of inVentiv Health, Mr. Krippendorff highlighted three key factors that have contributed to inVentiv's 520 percent revenue growth over the past eight years. They include having a mission that fosters innovation, combining different services to create new offerings, and engaging with clients as a strategic partner.

The blog postings can be found at and the interview with Mr. Walter can be downloaded at .

About inVentiv Health

inVentiv Health, Inc. (Nasdaq:VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit

The inVentiv Health, Inc. logo is available at

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
CONTACT:  inVentiv Health, Inc.          Investors / Corporate:          David Bassin, CFO            (732) 537-4804            Media:          Marcia Frederick            (614) 543-6281  

company logo